TARS - Tarsus Pharmaceuticals GAAP EPS of -$0.84 beats by $0.13 November, 09 2022 08:47 AM Tarsus Pharmaceuticals Inc. Tarsus Pharmaceuticals press release ( NASDAQ: TARS ): Q3 GAAP EPS of -$0.84 beats by $0.13 . As of September 30, 2022, cash, cash equivalents and marketable securities were $226.6 million For further details see: Tarsus Pharmaceuticals GAAP EPS of -$0.84 beats by $0.13